Ajay Rana

9PUBLICATIONS
24CO-AUTHORS
Haematological tumoursMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 10, 2024
MLK3 promotes prooncogenic signaling in hepatocellular carcinoma via TGFβ pathway.

Rong Ke, Navin Viswakarma, Mary Menhart

|Feb 22, 2023
TrkA expression directs the anti-neoplastic activity of MLK3 inhibitors in triple-negative breast cancer.

Rakesh Sathish Nair, Sandeep Kumar, Subhasis Das

|Sep 12, 2022
Mixed lineage kinase 3 and CD70 cooperation sensitize trastuzumab-resistant HER2+ breast cancer by ceramide-loaded nanoparticles.

Sandeep Kumar, Subhasis Das, Jingjing Sun

|Jul 05, 2022
Ets1 mediates sorafenib resistance by regulating mitochondrial ROS pathway in hepatocellular carcinoma.

Kanchan Vishnoi, Rong Ke, Navin Viswakarma

|Apr 27, 2022
Calcium channel blockers potentiate gemcitabine chemotherapy in pancreatic cancer.

Daniel R Principe, Alexandre F Aissa, Sandeep Kumar

|Jan 22, 2022
XP-524 is a dual-BET/EP300 inhibitor that represses oncogenic KRAS and potentiates immune checkpoint inhibition in pancreatic cancer.

Daniel R Principe, Rui Xiong, Yangfeng Li

Pageof 2

Frequent Collaborators

6 joint publications

Basabi Rana

6 joint publications

Sandeep Kumar

5 joint publications

Piush Srivastava

4 joint publications

Sunil Kumar Singh